These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12574669)

  • 41. Cognitive function and information processing in type 2 diabetes.
    Cosway R; Strachan MW; Dougall A; Frier BM; Deary IJ
    Diabet Med; 2001 Oct; 18(10):803-10. PubMed ID: 11678970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of glucose on nonmemory cognitive functioning in the elderly.
    Allen JB; Gross AM; Aloia MS; Billingsley C
    Neuropsychologia; 1996 May; 34(5):459-65. PubMed ID: 8861236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycemic control and treatment patterns in patients with heart failure.
    Tang WH
    Curr Cardiol Rep; 2007 May; 9(3):242-7. PubMed ID: 17470338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship between adult neuropsychological profiles and diabetic patients' glycemic control.
    Zihl J; Schaaf L; Zillmer EA
    Appl Neuropsychol; 2010 Jan; 17(1):44-51. PubMed ID: 20146121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetes. Can tight glycemic control in diabetes benefit cognition?
    Herzog RI; Sherwin RS
    Nat Rev Neurol; 2012 Jan; 8(3):124-6. PubMed ID: 22290574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of type 1 diabetes on cognitive performance: a meta-analysis.
    Brands AM; Biessels GJ; de Haan EH; Kappelle LJ; Kessels RP
    Diabetes Care; 2005 Mar; 28(3):726-35. PubMed ID: 15735218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved glycemic control with the multi-receptor tyrosine kinase inhibitor pazopanib.
    Böhm S; Hess D; Gillessen S; Brändle M
    Diabetes Care; 2010 Jun; 33(6):e82. PubMed ID: 20508227
    [No Abstract]   [Full Text] [Related]  

  • 48. Relationship between hyperglycemia and cognitive function in older NIDDM patients.
    Reaven GM; Thompson LW; Nahum D; Haskins E
    Diabetes Care; 1990 Jan; 13(1):16-21. PubMed ID: 2298111
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A longitudinal study of cognitive performance in noninsulin dependent (type II) diabetic men.
    Robertson-Tchabo EA; Arenberg D; Tobin JD; Plotz JB
    Exp Gerontol; 1986; 21(4-5):459-67. PubMed ID: 3493169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cognitive processes in insulin-dependent diabetes.
    Franceschi M; Cecchetto R; Minicucci F; Smizne S; Baio G; Canal N
    Diabetes Care; 1984; 7(3):228-31. PubMed ID: 6734391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Type 2 diabetes mellitus, cognition and brain in aging: A brief review.
    Kumar R; Looi JC; Raphael B
    Indian J Psychiatry; 2009 Jan; 51 Suppl 1(Suppl1):S35-8. PubMed ID: 21416014
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Choice enhances performance in non-insulin dependent diabetics and controls.
    Perlmuter LC
    J Gerontol; 1991 Sep; 46(5):P218-23. PubMed ID: 1890288
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Why is learning and memory dysfunction in Type 2 diabetes limited to older adults?
    Ryan CM; Geckle M
    Diabetes Metab Res Rev; 2000; 16(5):308-15. PubMed ID: 11025555
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies.
    Strachan MW; Deary IJ; Ewing FM; Frier BM
    Diabetes Care; 1997 Mar; 20(3):438-45. PubMed ID: 9051402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of diabetes mellitus II on cognitive performance.
    Silva JLD; Ribeiro LTC; Dos Santos NRP; Beserra VCAS; Fragoso YD
    Dement Neuropsychol; 2012; 6(2):80-84. PubMed ID: 29213778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive functioning is susceptible to the level of blood glucose.
    Donohoe RT; Benton D
    Psychopharmacology (Berl); 1999 Aug; 145(4):378-85. PubMed ID: 10460314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comment on Laiteerapong et al. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study). Diabetes Care 2019;42: 416-426.
    Hulman A; Bjerg L; Carstensen B
    Diabetes Care; 2019 Mar; 42(3):e45. PubMed ID: 30679306
    [No Abstract]   [Full Text] [Related]  

  • 58. [Antidiabetic treatments for the elderly].
    Picart C; Hoang S; Soudani M; Charbit J
    Soins Gerontol; 2023; 28(163):30-34. PubMed ID: 37716779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does Intensive Glucose Control Prevent Cognitive Decline in Diabetes? A Meta-Analysis.
    Peñaherrera-Oviedo C; Moreno-Zambrano D; Palacios M; Duarte-Martinez MC; Cevallos C; Gamboa X; Jurado MB; Tamariz L; Palacio A; Santibañez R
    Int J Chronic Dis; 2015; 2015():680104. PubMed ID: 26464871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cognition in elderly with type 1 diabetes: Is there an interaction between glycemia and aging?
    van Duinkerken E; Snoek FJ
    J Diabetes Complications; 2019 Jan; 33(1):4-5. PubMed ID: 30366826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.